NGI226 microparticles
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for NGI226 microparticles, covering 2026-03-30 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate the Safety, Tolerability and Preliminary Efficacy of NGI226 Microparticles in Patients With Achilles Tendinopathy [Phase 2]